Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
Neurogenic detrusor overactivity: an update on management options.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis.
Effect of a neurohospitalist service on outcomes at an academic medical center.
Status migrainosus as an initial presentation of multiple sclerosis.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability.
Effect of textured insoles on balance and gait in people with multiple sclerosis: an exploratory trial.
Effect of seasonal fluctuation of ambient temperature on fatigue in multiple sclerosis patients living in Attica, Greece.
Lower urinary tract symptoms associated with neurological conditions: Observations on a clinical sample of outpatients neurorehabilitation service.
Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
[Adaptative immunity and pathophysiology of multiple sclerosis.]
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
Osmotic Demyelination Syndrome as the Initial Manifestation of a Hyperosmolar Hyperglycemic State.
Digestion products of the PH20 hyaluronidase inhibit remyelination.
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
Merck Loses Protection for Patent on Zocor
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »